✦ LIBER ✦

Management of High Risk Metastatic Prostate Cancer: Defining Risk at the Time of Initial Treatment Failure

✍ Scribed by Chang, Sam S.

Book ID: 122033716
Publisher: Lippincott Williams and Wilkins
Year: 2006
Tongue: English
Weight: 58 KB
Volume: 176
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2006.06.068

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of High Risk Metastatic Prost

Management of High Risk Metastatic Prostate Cancer

📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 35 KB

Advances in the management of high-risk

Advances in the management of high-risk localised and metastatic prostate cancer

✍ Joaquim Bellmunt; Gerhardt Attard; Amit Bahl; Hartwig Huland; Laurence Klotz; De 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

Management of High Risk Metastatic Prost

Management of High Risk Metastatic Prostate Cancer: The Case for Novel Therapies

✍ Brand, Timothy C.; Tolcher, Anthony W. 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 79 KB

The Management of High Risk Prostate Can

The Management of High Risk Prostate Cancer

✍ AKDUMAN, BULENT; CRAWFORD, E. DAVID 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 98 KB

Initial management of prostate-specific

Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer

✍ Aizer, Ayal A.; Chen, Ming-Hui; Hattangadi, Jona; D'Amico, Anthony V. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Timing of biochemical failure and distan

Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy

✍ Peter B. Morgan; Alexandra L. Hanlon; Eric M. Horwitz; Mark K. Buyyounouski; Rob 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 628 KB

## Abstract ## BACKGROUND. The relation of prostate cancer risk‐group stratification and the timing of biochemical failure (BF) and distant metastasis (DM) is not well defined. The authors hypothesized that early failures due to subclinical micrometastasis at presentation could be differentiated f